Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.
Human opsonins directed against specific meningococcal outer membrane structures in sera obtained during meningococcal disease were quantified with a recently developed antigen-specific, opsonin-dependent phagocytosis and oxidative burst assay. Outer membrane vesicles (OMVs) and PorA (class 1) and PorB (class 3) proteins purified from mutants of the same strain (44/76; B:15:P1.7. 16) were adsorbed to fluorescent beads, opsonized with acute- and convalescent-phase sera from 40 patients with meningococcal disease, and exposed to human leukocytes. Flow cytometric quantitation of the resulting leukocyte phagocytosis products (PPs) demonstrated that disease-induced serum opsonins recognized meningococcal OMV components and both porins. The PPPorA and PPPorB values induced by convalescent-phase sera correlated positively with the PPOMV values. However, the PPPorB values were higher than the PPPorA values in convalescent-phase sera (medians [ranges] of 754 [17 to 1,057] and 107 [4 to 458], respectively) (P < 0.0001) and correlated positively with higher levels of immunoglobulin G against PorB than against PorA as evaluated by enzyme-linked immunosorbent assay. Extensive individual variations in the anti-OMV and antiporin serum opsonic activities between patients infected by serotypes and serosubtypes homologous and heterologous to the target antigens were observed. Simultaneously measured oxidative burst activity correlated with the opsonophagocytosis, an indication that both of these important steps in the in vitro phagocytic elimination of meningococci are initiated by opsonins directed against OMV components, including PorA and PorB. In conclusion, human patient opsonins against meningococcal OMV components and in particular PorB epitopes were identified by this new method, which might facilitate selection of opsonin-inducing meningococcal antigens for inclusion in future vaccines.
Lehmann
A K
AK
Medical Department B, University of Bergen, Bergen, Norway. Anne.Lehmann@medb.uib.no
Halstensen
A
A
Aaberge
I S
IS
Holst
J
J
Michaelsen
T E
TE
Sornes
S
S
Wetzler
L M
LM
Guttormsen
H
H
D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007962:Leukocytes / Q000276:immunology; D008297:Male; D008585:Meningitis, Meningococcal / Q000276:immunology; D008589:Meningococcal Infections / Q000276:immunology*; D018613:Microscopy, Confocal; D008875:Middle Aged; D009345:Neisseria meningitidis / Q000276:immunology*; D009895:Opsonin Proteins / Q000096:biosynthesis / Q000097:blood / Q000276:immunology*; D010587:Phagocytosis; D018272:Porins / Q000276:immunology*; D016897:Respiratory Burst
D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D009895:Opsonin Proteins; D018272:Porins; C057699:porin protein, Neisseria